175 related articles for article (PubMed ID: 22780206)
21. ESH-SIOG International Conference on Haematological Malignancies in the Elderly.
Balducci L
Expert Rev Hematol; 2010 Dec; 3(6):675-7. PubMed ID: 21091143
[TBL] [Abstract][Full Text] [Related]
22. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
[No Abstract] [Full Text] [Related]
23. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.
Styczynski J; Reusser P; Einsele H; de la Camara R; Cordonnier C; Ward KN; Ljungman P; Engelhard D;
Bone Marrow Transplant; 2009 May; 43(10):757-70. PubMed ID: 19043458
[TBL] [Abstract][Full Text] [Related]
24. [Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients].
Medinger P; Tissot JD; Nicoloso de Faveri G; Kovacsovics TJ; Perey L; Schneider P; Zwicky C
Schweiz Med Wochenschr; 2000 Apr; 130(13):478-84. PubMed ID: 10812643
[TBL] [Abstract][Full Text] [Related]
25. American society of hematology-45th annual meeting and exposition: hematological malignancies.
Davies J
IDrugs; 2004 Jan; 7(1):1-3. PubMed ID: 14968766
[No Abstract] [Full Text] [Related]
26. Summer happenings in Hematology 2011. Highlights in Hematological Malignancies form the 2011 American Society Clinical Oncology Annual Meeting and the 16th Congress of the European Hematology Association, and the 11th International Conference on Malignancy Lymphoma.
Ashforth E; Cheson BD
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 17):1-24. PubMed ID: 22361949
[No Abstract] [Full Text] [Related]
27. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
28. Battling the hematological malignancies: the 200 years' war.
Lichtman MA
Oncologist; 2008 Feb; 13(2):126-38. PubMed ID: 18305057
[TBL] [Abstract][Full Text] [Related]
29. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
30. Hematological malignancies: a primer.
Haddad RY
Dis Mon; 2012 Apr; 58(4):151-2. PubMed ID: 22449364
[No Abstract] [Full Text] [Related]
31. Second allografts for relapsed hematologic malignancies: feasibility of using a different donor.
Duus JE; Stiff PJ; Choi J; Parthasarathy M; Rodriguez T; Toor AA
Bone Marrow Transplant; 2005 Feb; 35(3):261-4. PubMed ID: 15558039
[TBL] [Abstract][Full Text] [Related]
32. [Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)].
Ishitsuka K; Ikeda S; Izumi Y; Imamura Y; Uike N; Uozumi K; Utsunomiya A; Kawano F; Kubuki Y; Gondo H; Saburi Y; Sibuya T; Suzusima J; Tsukada J; Hayashi M; Maeda K; Matuishi E; Matsuoka H; Makino S; Tamura K
Rinsho Ketsueki; 2003 Jul; 44(7):483-90. PubMed ID: 12931571
[TBL] [Abstract][Full Text] [Related]
33. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():390-4. PubMed ID: 17474435
[No Abstract] [Full Text] [Related]
34. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
36. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
37. Hematopoietic growth factors in hematological malignancies.
Kumar R; Rao RR; Ranjan S
J Assoc Physicians India; 1995; Suppl 3():5-10. PubMed ID: 8773114
[No Abstract] [Full Text] [Related]
38. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
[TBL] [Abstract][Full Text] [Related]
39. Manipulation of the stem cell as a target for hematologic malignancies.
Ballen KK; Becker PS; Stewart FM; Quesenberry PJ
Semin Oncol; 2000 Oct; 27(5):512-23. PubMed ID: 11049019
[TBL] [Abstract][Full Text] [Related]
40. [Nonmyeloablative allogeneic stem cell transplantation in elder patients with hematological malignancies].
Yoshida T
Rinsho Ketsueki; 2004 Feb; 45(2):132-8. PubMed ID: 15045821
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
